PMDA drug package insert
セファランチン注10mg
PMDA Prescription drug · メディサ新薬株式会社 · package insert Sep 29, 2023
Key facts
| Brand names | セファランチン注10mg |
|---|---|
| Nonproprietary names | セファランチン |
| Companies | 製造販売元／メディサ新薬株式会社, 発売元／化研生薬株式会社 |
| Product type | Prescription drug |
| Therapeutic category | タマサキツヅラフジ抽出アルカロイド製剤 |
| Therapeutic category codes | 87290 |
| YJ codes | 2900400A2034 |
| Approval numbers | 21300AMZ00648000 |
| Package insert edition | 第1版 |
| Package insert date | Sep 29, 2023 |
| PMDA document key | 780075_2900400A2034_2 |
| PMDA company code | 780075 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: